BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25419511)

  • 1. Low-molecular-weight heparin modulates vein wall fibrotic response in a plasminogen activator inhibitor 1-dependent manner.
    Obi AT; Diaz JA; Ballard-Lipka NL; Roelofs KJ; Farris DM; Lawrence DA; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2014 Oct; 2(4):441-450.e1. PubMed ID: 25419511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.
    Sood V; Luke C; Miller E; Mitsuya M; Upchurch GR; Wakefield TW; Myers DD; Henke PK
    Ann Vasc Surg; 2010 Feb; 24(2):233-41. PubMed ID: 20142002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.
    Obi AT; Diaz JA; Ballard-Lipka NL; Roelofs KJ; Farris DM; Lawrence DA; Wakefield TW; Henke PK
    J Thromb Haemost; 2014 Aug; 12(8):1353-63. PubMed ID: 24943740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
    Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
    J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.
    Moaveni DK; Lynch EM; Luke C; Sood V; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2008 Mar; 47(3):616-24. PubMed ID: 18295113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
    Diaz JA; Ballard-Lipka NE; Farris DM; Hawley AE; Wrobleski SK; Myers DD; Henke PK; Lawrence DA; Wakefield TW
    J Vasc Surg; 2012 Mar; 55(3):815-22. PubMed ID: 22119245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.
    Myers DD; Henke PK; Bedard PW; Wrobleski SK; Kaila N; Shaw G; Meier TR; Hawley AE; Schaub RG; Wakefield TW
    J Vasc Surg; 2006 Sep; 44(3):625-32. PubMed ID: 16950445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model.
    Thanaporn P; Myers DD; Wrobleski SK; Hawley AE; Farris DM; Wakefield TW; Henke PK
    Surgery; 2003 Aug; 134(2):365-71. PubMed ID: 12947342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system.
    Feng Y; Zhang F; Niu L; Zhang M
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):531-41. PubMed ID: 27273142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
    Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model.
    Myers DD; Henke PK; Wrobleski SK; Hawley AE; Farris DM; Chapman AM; Knipp BS; Thanaporn P; Schaub RG; Greenfield LJ; Wakefield TW
    J Vasc Surg; 2002 Nov; 36(5):928-38. PubMed ID: 12422103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of interleukin-6 and its effect on late vein wall injury in a stasis mouse model of deep vein thrombosis.
    Dowling AR; Luke CE; Cai Q; Pellerito AM; Obi AT; Henke PK
    JVS Vasc Sci; 2022; 3():246-255. PubMed ID: 35647566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.
    Siefert SA; Chabasse C; Mukhopadhyay S; Hoofnagle MH; Strickland DK; Sarkar R; Antalis TM
    J Thromb Haemost; 2014 Oct; 12(10):1706-16. PubMed ID: 25041188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep vein thrombosis resolution is not accelerated with increased neovascularization.
    Varma MR; Moaveni DM; Dewyer NA; Varga AJ; Deatrick KB; Kunkel SL; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2004 Sep; 40(3):536-42. PubMed ID: 15337885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring.
    Kessinger CW; Kim JW; Henke PK; Thompson B; McCarthy JR; Hara T; Sillesen M; Margey RJ; Libby P; Weissleder R; Lin CP; Jaffer FA
    PLoS One; 2015; 10(2):e0116621. PubMed ID: 25680183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.
    Dewyer NA; Sood V; Lynch EM; Luke CE; Upchurch GR; Wakefield TW; Kunkel S; Henke PK
    J Surg Res; 2007 Oct; 142(2):357-63. PubMed ID: 17574586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-selectin inhibitor is superior to low-molecular-weight heparin for the treatment of experimental venous thrombosis.
    Myers DD; Ning J; Lester P; Adili R; Hawley A; Durham L; Dunivant V; Reynolds G; Crego K; Sood S; Sigler R; Fogler WE; Magnani JL; Holinstat M; Wakefield T
    J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):211-220. PubMed ID: 33872819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
    Dahi S; Lee JG; Lovett DH; Sarkar R
    J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.
    Li W; Kessinger CW; Orii M; Lee H; Wang L; Weinberg I; Jaff MR; Reed GL; Libby P; Tawakol A; Henke PK; Jaffer FA
    Circulation; 2021 Mar; 143(12):1224-1238. PubMed ID: 33445952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT.
    Deatrick KB; Obi A; Luke CE; Elfline MA; Sood V; Upchurch GR; Jaffer F; Wakefield TW; Henke PK
    Thromb Res; 2013 Sep; 132(3):360-6. PubMed ID: 23978304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.